Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01852591 · ClinicalTrials.gov registry record · NA
Exploration of Immune Response to Early PCV13 Vaccination in Conjunction With Autologous Transplant
A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT01852591: Completed NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT01852591 is a NA study that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01852591, a NA study, has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
There is no study hypothesis. The purpose of this study is to see if the Pneumococcal conjugate vaccine (PCV13), when administered before and early after an autologous peripheral stem cell transplant will induce an immune response.
Primary Outcome
Positive response per test category. Post-vaccination result higher than pre-vaccination values for each test category criteria. Additional details are reported under Secondary Outcome Measures.
Interventions
- BIOLOGICAL PCV 13
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2013-02 |
| Est. Completion | 2016-10 |
| Phase | NA |
What the finished NCT01852591 record still lists
NCT01852591 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which PCV 13 is the first listed.
NCT01852591 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01852591 about?
NCT01852591 is a clinical study titled "Exploration of Immune Response to Early PCV13 Vaccination in Conjunction With Autologous Transplant". There is no study hypothesis. The purpose of this study is to see if the Pneumococcal conjugate vaccine (PCV13), when administered before and early after an autologous peripheral stem cell transplant will induce an immune response.
What is the current status of trial NCT01852591?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2013-02. Estimated completion is 2016-10.
What interventions are being tested in trial NCT01852591?
The interventions under investigation include: PCV 13 (BIOLOGICAL).
Who is sponsoring clinical trial NCT01852591?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01852591's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia